These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 23303402)

  • 1. 11β-Hydroxysteroid dehydrogenase type 2 in hypertension: comparison of phenotype and genotype analysis.
    Kosicka K; Cymerys M; Majchrzak-Celińska A; Chuchracki M; Główka FK
    J Hum Hypertens; 2013 Aug; 27(8):510-5. PubMed ID: 23303402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of renal 11beta-hydroxysteroid dehydrogenase type 2 is decreased in patients with impaired renal function.
    Quinkler M; Zehnder D; Lepenies J; Petrelli MD; Moore JS; Hughes SV; Cockwell P; Hewison M; Stewart PM
    Eur J Endocrinol; 2005 Aug; 153(2):291-9. PubMed ID: 16061836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-dependent decrease in 11beta-hydroxysteroid dehydrogenase type 2 (11beta-HSD2) activity in hypertensive patients.
    Henschkowski J; Stuck AE; Frey BM; Gillmann G; Dick B; Frey FJ; Mohaupt MG
    Am J Hypertens; 2008 Jun; 21(6):644-9. PubMed ID: 18443572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 11beta-Hydroxysteroid dehydrogenase type 2 activity is associated with left ventricular mass in essential hypertension.
    Glorioso N; Filigheddu F; Parpaglia PP; Soro A; Troffa C; Argiolas G; Mulatero P
    Eur Heart J; 2005 Mar; 26(5):498-504. PubMed ID: 15618035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of Urinary Exosomal HSD11B2 mRNA Expression: A Useful Novel Tool for the Diagnostic Approach of Dysfunctional 11β-HSD2-Related Hypertension.
    De Santis D; Castagna A; Danese E; Udali S; Martinelli N; Morandini F; Veneri M; Bertolone L; Olivieri O; Friso S; Pizzolo F
    Front Endocrinol (Lausanne); 2021; 12():681974. PubMed ID: 34497581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 11β-hydroxysteroid dehydrogenase type 2 polymorphisms and activity in a Chilean essential hypertensive and normotensive cohort.
    Campino C; Quinteros H; Owen GI; Carvajal CA; Morales M; Olivieri O; Guidi G; Faccini G; Pasini F; Baudrand R; Padilla O; Valdivia C; Thichauer J; Lagos CF; Kalergis AM; Fardella CE
    Am J Hypertens; 2012 May; 25(5):597-603. PubMed ID: 22278213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of water loading on the urinary ratio of cortisone to cortisol in healthy subjects and a new approach to the evaluation of the ratio as an index for in vivo human 11β-hydroxysteroid dehydrogenase 2 activity.
    Yokokawa A; Takasaka T; Shibasaki H; Kasuya Y; Kawashima S; Yamada A; Furuta T
    Steroids; 2012 Oct; 77(12):1291-7. PubMed ID: 22850318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HPLC method for determination of fluorescence derivatives of cortisol, cortisone and their tetrahydro- and allo-tetrahydro-metabolites in biological fluids.
    Główka FK; Kosicka K; Karaźniewicz-Łada M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Feb; 878(3-4):283-9. PubMed ID: 20018571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A simple LC-MS/MS method for the determination of cortisol, cortisone and tetrahydro-metabolites in human urine: assay development, validation and application in depression patients.
    Zhai X; Chen F; Zhu C; Lu Y
    J Pharm Biomed Anal; 2015 Mar; 107():450-5. PubMed ID: 25668797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucocorticoid Metabolism in Hypertensive Disorders of Pregnancy: Analysis of Plasma and Urinary Cortisol and Cortisone.
    Kosicka K; Siemiątkowska A; Krzyścin M; Bręborowicz GH; Resztak M; Majchrzak-Celińska A; Chuchracki M; Główka FK
    PLoS One; 2015; 10(12):e0144343. PubMed ID: 26637176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-related changes in 11β-hydroxysteroid dehydrogenase type 2 activity in normotensive subjects.
    Campino C; Martinez-Aguayo A; Baudrand R; Carvajal CA; Aglony M; Garcia H; Padilla O; Kalergis AM; Fardella CE
    Am J Hypertens; 2013 Apr; 26(4):481-7. PubMed ID: 23443726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired protein stability of 11beta-hydroxysteroid dehydrogenase type 2: a novel mechanism of apparent mineralocorticoid excess.
    Atanasov AG; Ignatova ID; Nashev LG; Dick B; Ferrari P; Frey FJ; Odermatt A
    J Am Soc Nephrol; 2007 Apr; 18(4):1262-70. PubMed ID: 17314322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the 11beta-hydroxysteroid dehydrogenase type 2 gene (HSD11B2) in human essential hypertension.
    Mariniello B; Ronconi V; Sardu C; Pagliericcio A; Galletti F; Strazzullo P; Palermo M; Boscaro M; Stewart PM; Mantero F; Giacchetti G
    Am J Hypertens; 2005 Aug; 18(8):1091-8. PubMed ID: 16109323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical and genetic characterization of 11 beta-hydroxysteroid dehydrogenase type 2 in low-renin essential hypertensives.
    Carvajal CA; Romero DG; Mosso LM; González AA; Campino C; Montero J; Fardella CE
    J Hypertens; 2005 Jan; 23(1):71-7. PubMed ID: 15643127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 11beta-hydroxysteroid dehydrogenase 2 activity is elevated in severe obesity and negatively associated with insulin sensitivity.
    Müssig K; Remer T; Haupt A; Gallwitz B; Fritsche A; Häring HU; Maser-Gluth C
    Obesity (Silver Spring); 2008 Jun; 16(6):1256-60. PubMed ID: 18421276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of HSD11B2 polymorphisms in essential hypertension and the diuretic response to thiazides.
    Williams TA; Mulatero P; Filigheddu F; Troffa C; Milan A; Argiolas G; Parpaglia PP; Veglio F; Glorioso N
    Kidney Int; 2005 Feb; 67(2):631-7. PubMed ID: 15673310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uninephrectomy reduces 11β-hydroxysteroid dehydrogenase type 1 and type 2 concomitantly with an increase in blood pressure in rats.
    Lauterburg M; Escher G; Dick B; Ackermann D; Frey FJ
    J Endocrinol; 2012 Sep; 214(3):373-80. PubMed ID: 22739210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary free cortisol is not a biochemical marker of hypertension.
    Krall P; Carvajal C; Ortiz E; Muñoz C; Garrido JL; Mosso L; Fardella C
    Am J Hypertens; 2007 Apr; 20(4):459-65. PubMed ID: 17386356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apparent mineralocorticoid excess: report of six new cases and extensive personal experience.
    Morineau G; Sulmont V; Salomon R; Fiquet-Kempf B; Jeunemaître X; Nicod J; Ferrari P
    J Am Soc Nephrol; 2006 Nov; 17(11):3176-84. PubMed ID: 17035606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired 11β-Hydroxysteroid Dehydrogenase Type 2 in Glucocorticoid-Resistant Patients.
    Vitellius G; Delemer B; Caron P; Chabre O; Bouligand J; Pussard E; Trabado S; Lombes M
    J Clin Endocrinol Metab; 2019 Nov; 104(11):5205-5216. PubMed ID: 31225872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.